Evaluation of the SCALED (SCaling AcceptabLE cDs) Approach for the Implementation of Interoperable CDS for Venous Thromboembolism Prevention

对实施可互操作 CDS 预防静脉血栓栓塞的 SCALED(Scaling Acceptable CDS)方法进行评估

基本信息

  • 批准号:
    10675563
  • 负责人:
  • 金额:
    $ 97.77万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2022
  • 资助国家:
    美国
  • 起止时间:
    2022-08-05 至 2025-07-31
  • 项目状态:
    未结题

项目摘要

ABSTRACT/PROJECT SUMMARY There is a global emphasis and critical need to close the patient-centered outcomes research (PCOR) evidence to practice gap. Forty percent of patients do not receive evidence-based practice, 20% receive unnecessary or potentially harmful care, and sadly, the list continues. We believe interoperable clinical decision support (CDS) is an indispensable solution to help close this gap; however, poor design, lack of interoperability, and implementation barriers hinder broad adoption. At the University of Minnesota, we have extensive experience implementing and scaling user-centered CDS systems, with over 20 use cases scaled each year. Importantly, we have developed and implemented both interoperable and federally-funded CDS systems. Our healthcare system leverages a rigorous approach, SCALED (SCaling AcceptabLE cDs), to guide CDS scaling across the system. But, the current climate of each healthcare system developing “home-grown” CDS for the exact same guidelines is not tenable. Building capabilities to rapidly translate PCOR to the bedside at scale and share interoperable CDS routinely with an updated knowledge base (living evidence synthesis) is necessary. Given this, we partnered with Apervita, developers of a healthcare technology platform for digital quality measurement and decision support, to develop an interoperable clinical practice guideline leveraging CPG-on-FHIR (Fast Healthcare Interoperability Resources) to prevent inpatient COVID-19 venous thromboembolism (VTE). The proposed R18 project will adapt a currently deployed CDS system to also deliver a VTE prevention guideline for adult patients with traumatic brain injury (TBI). We believe this is an ideal PCOR use case given PCORI’s continued effort to combat VTE in trauma and our experience previously implementing this guideline. Our overall goal is to successfully scale, evaluate, and maintain an interoperable TBI CDS across our 4-institution collaborative network. For Aim 1, we will conduct a Hybrid Type 2 randomized stepped wedge effectiveness- implementation trial to scale the CDS across 4 heterogeneous healthcare systems. Trial outcomes will be assessed using RE-AIM. Despite best efforts, it highly likely CDS adoption will vary across each site; Aim 2 will allow us to understand why. In Aim 2, we will evaluate implementation processes across trial sites guided by the EPIS implementation framework (determinant framework) using mixed-methods. Finally, it is critical that PCOR CPGs are maintained as evidence evolves. To date an accepted process for evidence maintenance does not exist. In Aim 3, we will pilot a “Living Guideline” process model for the VTE prevention CDS systems. Ultimately, this project will scale CDS across a diverse collaborative CDS community serving as an important demonstration of this critical healthcare challenge. We will integrate lessons learned for a planned national scaling in collaboration with engagement of U.S. trauma societies. Importantly, we will develop electronic health record (EHR)-specific IT playbooks for integration of interoperable CDS. Finally, we will pilot an approach for the “Living Guideline” and use that to sustain evidenced-based decision logic.
抽象/项目总结

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Genevieve B Melton-Meaux其他文献

Genevieve B Melton-Meaux的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Genevieve B Melton-Meaux', 18)}}的其他基金

I CAN DO Surgical ACP (Improving Completion, Accuracy, and Dissemination Of Surgical Advanced Care Planning) Trial
I CAN DO Surgical ACP(提高外科高级护理计划的完成度、准确性和传播)试验
  • 批准号:
    10649843
  • 财政年份:
    2023
  • 资助金额:
    $ 97.77万
  • 项目类别:
Evaluation of the SCALED (SCaling AcceptabLE cDs) Approach for the Implementation of Interoperable CDS for Venous Thromboembolism Prevention
对实施可互操作 CDS 预防静脉血栓栓塞的 SCALED(Scaling Acceptable CDS)方法进行评估
  • 批准号:
    10494692
  • 财政年份:
    2022
  • 资助金额:
    $ 97.77万
  • 项目类别:
Discovery and Visualization of New Information from Clinical Reports in the EHR
EHR 中临床报告的新信息的发现和可视化
  • 批准号:
    8476978
  • 财政年份:
    2013
  • 资助金额:
    $ 97.77万
  • 项目类别:
Discovery and Visualization of New Information from Clinical Reports in the EHR
EHR 中临床报告的新信息的发现和可视化
  • 批准号:
    8739634
  • 财政年份:
    2013
  • 资助金额:
    $ 97.77万
  • 项目类别:
Discovery and Visualization of New Information from Clinical Reports in the EHR
EHR 中临床报告的新信息的发现和可视化
  • 批准号:
    8930998
  • 财政年份:
    2013
  • 资助金额:
    $ 97.77万
  • 项目类别:
Discovery and Visualization of New Information from Clinical Reports in the EHR
EHR 中临床报告的新信息的发现和可视化
  • 批准号:
    9145182
  • 财政年份:
    2013
  • 资助金额:
    $ 97.77万
  • 项目类别:

相似海外基金

BAMBOO - Build scAled Modular Bamboo-inspired Offshore sOlar systems
BAMBOO - 构建规模化模块化竹子式海上太阳能系统
  • 批准号:
    10109981
  • 财政年份:
    2024
  • 资助金额:
    $ 97.77万
  • 项目类别:
    EU-Funded
SIMPLE - Scaled up Innovative Motor Production for Lower Environmental impact
简单 - 扩大创新电机生产规模以降低环境影响
  • 批准号:
    10077373
  • 财政年份:
    2023
  • 资助金额:
    $ 97.77万
  • 项目类别:
    BEIS-Funded Programmes
Optimized Up-scaled Technology for Next Generation Solid Oxide Electrolysis
下一代固体氧化物电解的优化放大技术
  • 批准号:
    10063108
  • 财政年份:
    2023
  • 资助金额:
    $ 97.77万
  • 项目类别:
    EU-Funded
Scaled Production of Aerogel-based materials for Commercial Exploitation (SPACE)
用于商业开发的气凝胶基材料的规模生产(SPACE)
  • 批准号:
    10036764
  • 财政年份:
    2023
  • 资助金额:
    $ 97.77万
  • 项目类别:
    Collaborative R&D
Workshops on Smart Manufacturing with Open and Scaled Data Sharing in Semiconductor and Microelectronics Manufacturing; Virtual and In-Person; Washington, DC; October/November 2023
半导体和微电子制造中开放和规模化数据共享的智能制造研讨会;
  • 批准号:
    2334590
  • 财政年份:
    2023
  • 资助金额:
    $ 97.77万
  • 项目类别:
    Standard Grant
Exploring the multi-scaled nature of solar vortices with DKIST
与 DKIST 一起探索太阳涡旋的多尺度性质
  • 批准号:
    2878221
  • 财政年份:
    2023
  • 资助金额:
    $ 97.77万
  • 项目类别:
    Studentship
Unique Scaled Manufacture - Combining generative ai & colour 3D printing to create 1/1 unique products
独特的规模化制造——结合生成式人工智能
  • 批准号:
    10068011
  • 财政年份:
    2023
  • 资助金额:
    $ 97.77万
  • 项目类别:
    Collaborative R&D
A scaled and sustainable demand responsive transport service
规模化且可持续的需求响应运输服务
  • 批准号:
    EP/X020835/1
  • 财政年份:
    2023
  • 资助金额:
    $ 97.77万
  • 项目类别:
    Research Grant
Quantitative modelling of SCALED material properties
SCALED 材料特性的定量建模
  • 批准号:
    10050058
  • 财政年份:
    2023
  • 资助金额:
    $ 97.77万
  • 项目类别:
    Grant for R&D
Scaled production of materials for use in direct air capture (DAC) of CO2
规模化生产用于直接空气捕获 (DAC) 二氧化碳的材料
  • 批准号:
    2887905
  • 财政年份:
    2023
  • 资助金额:
    $ 97.77万
  • 项目类别:
    Studentship
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了